Stay updated on Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.

Latest updates to the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page
- Check6 days agoChange DetectedThe Record History now lists a new revision entry: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history and the prior government funding notice was removed.SummaryDifference0.9%

- Check41 days agoChange DetectedA site-wide funding notice was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check48 days agoChange DetectedThe study history page adds a glossary toggle and a new Revision: v3.4.0 label, with additions shown in green and deletions in red to clarify changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedThe study record history now includes a new revision entry v3.3.4 and removes the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.